Skip to main content
. 2023 Aug 4;16:813–820. doi: 10.2147/JAA.S418658

Figure 4.

Figure 4

Duration of uncontrolled GINA step 4/5 asthma. Every fourth patient had continuous indications of uncontrolled GINA step 4/5 asthma over at least 3 years (years analyzed 2015–2019).

Notes: Mod. acc. IQVIA LRx MAT 12/2019; Patient cohort “GINA step 4/5 asthma” with at least 1 prescription from a pulmonologist.

Abbreviations: SABA, short-acting β2-agonist; OCS, oral corticosteroid.